- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07767734
Comparison of the BOPPPS Model and Traditional Instructional Method in Medicinal Chemistry Education
11 de agosto de 2026 atualizado por: Liang Qi, Jiangsu Medical College
Comparison of the BOPPPS Model and Traditional Instructional Method in Medicinal Chemistry Education for Pharmacy Students
This study aims to compare the teaching effect of the BOPPPS teaching model and the traditional lecture-based teaching method in Medicinal Chemistry courses for pharmacy students.
Two groups of students receiving different teaching strategies will be included in this retrospective controlled study.
The primary evaluation indicators include students' final examination scores, and secondary indicators cover classroom learning engagement and student satisfaction questionnaires.
The overall objective is to explore whether the BOPPPS model can improve students' learning performance and learning experience in Medicinal Chemistry teaching.
No human clinical intervention or invasive testing is involved in this educational research.
Visão geral do estudo
Status
Concluído
Intervenção / Tratamento
Descrição detalhada
This educational controlled study focuses on the teaching reform of Medicinal Chemistry, a core compulsory course for pharmacy majors in higher vocational colleges.
Traditional lecture-centered teaching is widely adopted in vocational pharmacy teaching, which often leads to insufficient student participation, weak initiative in classroom interaction, and unsatisfactory learning efficiency for complex pharmaceutical chemical structures and synthetic reactions.The BOPPPS teaching model divides each class into six standardized links: Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment, Summary.
This student-centered teaching design strengthens classroom interaction and targeted detection of learning effects.
At present, there is limited comparative research on the application of this model in Medicinal Chemistry teaching for vocational pharmacy students.This retrospective controlled research collects historical teaching data of two student groups receiving different teaching modes.
The research intends to systematically analyze the differences in learning outcomes between the two teaching strategies, so as to provide practical teaching reform references for Medicinal Chemistry courses in vocational pharmacy education.
This study only adopts routine classroom teaching and anonymous questionnaire surveys, without any clinical medical intervention, blood sampling or physical examination on participants.
All student data are anonymized to protect personal privacy.
Article 32 of the Notice on Printing and Distributing the Measures for Ethical Review of Life Science and Medical Research Involving Humans, jointly issued by the National Health Commission of China, the Ministry of Education, the Ministry of Science and Technology, and the National Administration of Traditional Chinese Medicine, stipulates that "Life science and medical research involving humans that uses human information, data or biological samples may be exempt from ethical review if such research falls under the circumstances specified below, causes no physical harm to human participants, and does not involve sensitive personal information or commercial interests."
As a study focusing on teaching effectiveness, the present research qualifies for an exemption from ethical review pursuant to this provision.
Tipo de estudo
Intervencional
Inscrição (Real)
60
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Jiangsu
-
Yancheng, Jiangsu, China, 224005
- Jiangsu Medical College
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
Aceita Voluntários Saudáveis
Sim
Descrição
Inclusion Criteria:
- Full-time pharmacy students without previous Medicinal Chemistry learning experience
- Complete all academic assessments and anonymous questionnaire surveys
Exclusion Criteria:
- Classroom attendance rate less than 80%
- Students who are unwilling to provide relevant data for this educational study or miss the final exam
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Experimental Group (BOPPPS Teaching Model)
Pharmacy students receive Medicinal Chemistry courses adopting the complete six-link BOPPPS teaching design, including Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment and Summary.
Interactive classroom activities and in-class tests are arranged in each lesson.
|
Medicinal Chemistry teaching based on BOPPPS model, consisting of Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment and Summary sessions with abundant classroom interaction.
|
|
Comparador Ativo: Control Group (Traditional Lecture Teaching)
Pharmacy students receive teacher-centered traditional lecture-based Medicinal Chemistry teaching.
The teacher explains knowledge points directly, with few classroom interactive sessions.
|
Traditional teacher-centered lecture teaching for Medicinal Chemistry, mainly knowledge explanation, without segmented pre-assessment and post-assessment arrangements.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Final examination scores of Medicinal Chemistry
Prazo: At the completion of the teaching intervention, up to 1 week
|
Final exam scores to evaluate students' mastery of professional knowledge of Medicinal Chemistry.
Scores range from 0 to 100.
Higher scores indicate better academic performance.
|
At the completion of the teaching intervention, up to 1 week
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Student teaching satisfaction score
Prazo: At the completion of the teaching intervention, up to 1 week
|
Score from an anonymous questionnaire evaluating students' satisfaction with the classroom teaching model.
The total score ranges from 1 to 5. Higher scores indicate higher satisfaction.
|
At the completion of the teaching intervention, up to 1 week
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Liang Qi, PhD, Jiangsu Medical College
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
15 de setembro de 2025
Conclusão Primária (Real)
6 de janeiro de 2026
Conclusão do estudo (Real)
8 de janeiro de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
6 de agosto de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
11 de agosto de 2026
Primeira postagem (Real)
17 de agosto de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
17 de agosto de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
11 de agosto de 2026
Última verificação
1 de agosto de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- JiangsuMC-20260806
- 2025JGYB272 (Número de outro subsídio/financiamento: Jiangsu Society of Higher Education)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
SIM
Descrição do plano IPD
De-identified individual participant-level data supporting this study, together with a complete data dictionary, will be accessible to qualified external researchers upon reasonable written request after the primary manuscript is published.
Data release is conditional on institutional and regulatory privacy authorization.
All formal data access requests should be submitted to the corresponding author for evaluation and review.
No identifiable personal information will be included in shared datasets to protect student privacy.
Prazo de Compartilhamento de IPD
De-identified individual participant data and supporting documents will be available to qualified researchers indefinitely after the publication of the primary study manuscript.
Critérios de acesso de compartilhamento IPD
Data and supporting documents are available only to qualified academic researchers with legitimate educational research objectives.
All applicants shall submit a formal written research request to the corresponding author.
Data release is subject to institutional privacy and regulatory authorization.
Applicants must provide a clear research plan and agree to use the shared de-identified data solely for independent academic research, without attempting to re-identify participants or share datasets with third parties.
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CIF
- ANALYTIC_CODE
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .